Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy

Journal of Clinical Microbiology

Volumn 51, Issue 10, 2013, Pages 3415-3417

  White, Christine ^a,b   Keegan, Helen ^a,b   Pilkington, Loretto ^b   Ruttle, Carmel ^b   Kerr, Patrick ^b   Sharp, Linda ^c   O'Toole, Sharon ^a   Turner, Michael ^b   Prendiville, Walter ^b   D'Arcy, Tom ^b   Fitzpatrick, Myra ^d   Lenehan, Peter ^d   Flannelly, Grainne ^d   O'Leary, John J ^a,b   Martin, Cara M ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b Tallaght and Coombe Women's and Infant's University Hospital   (Ireland)

^c NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^d NATIONAL MATERNITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

EID: 84884747492     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01949-13     Document Type: Article

References (7)

1. Lindemann ML, Dominquez MJ, de Antonio JC, Sandri MT., Tricca A, Sideri M, Khiri H, Ravel S, Boyle S, Aldrich C, Halfon P. 2012. Analytical comparsion of the cobas HPV test with Hybrid Capture 2 for detection of high-risk HPV genotypes. J. Mol. Diagn. 14:65-70.
2. Poljak M, Marin IJ, Seme K, Vince A. 2002. Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J. Clin. Virol. 25(Suppl 3):S89-S97. (Pubitemid 35441020)
3. Lapierre SG, Sauthier P, Mayrand MH, Dufresne S, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis MJ, Michon B, Ouellet S, Hadjeres R, Ferenczy A, Franco EL, Coutlée F. 2012. Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. J. Clin. Microbiol. 50:1240-1244.
4. Stoler MH, Wright TC, Sharma A, Apple R, Gutekunst K, Wright TL; ATHENA (Addressing THE Need for Advanced HPV Diagnostics) Study Group HPV. 2011. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am. J. Clin. Pathol. 135:468-475.
5. Gage JC, Sadorra M, LaMere BJ, Kail R, Aldrich C, Kinney W, Fetterman B, Lorey T, Schiffman M, Castle PE. 2012. Comparison of the cobas human papillomavirus (HPV) test with the Hybrid Capture 2 and linear array HPV DNA tests. J. Clin. Microbiol. 50:61-65.
6. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon, D. 2006 American Society for Colposcopy and Cervical Pathologysponsored Consensus Conference. 2007. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J. Low Genit. Tract Dis. 11:201-222. (Pubitemid 47530909)
7. CervicalCheck.2010. September 2009-August 2010 program report. CS/PR/PM-15 rev 1. CervicalCheck, Limerick, Ireland.